309 related articles for article (PubMed ID: 22709619)
21. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
22. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
Yoshida K; Ito M; Matsuoka I
Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
[TBL] [Abstract][Full Text] [Related]
23. Extracellular nucleotides and nucleosides as signalling molecules.
Giuliani AL; Sarti AC; Di Virgilio F
Immunol Lett; 2019 Jan; 205():16-24. PubMed ID: 30439478
[TBL] [Abstract][Full Text] [Related]
24. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
Dubyak GR; el-Moatassim C
Am J Physiol; 1993 Sep; 265(3 Pt 1):C577-606. PubMed ID: 8214015
[TBL] [Abstract][Full Text] [Related]
25. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
26. How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides.
Roszek K; Wujak M
J Cell Physiol; 2018 Jan; 234(1):320-334. PubMed ID: 30078187
[TBL] [Abstract][Full Text] [Related]
27. Characterization of E-NTPDase (EC 3.6.1.5) activity in hepatic lymphocytes: A different activity profile from peripheral lymphocytes.
Doleski PH; Adefegha SA; Cabral FL; Leal DB
Cell Biochem Funct; 2017 Mar; 35(2):105-112. PubMed ID: 28217922
[TBL] [Abstract][Full Text] [Related]
28. Characterization of soluble CD39 (SolCD39/NTPDase1) from PiggyBac nonviral system as a tool to control the nucleotides level.
Beckenkamp LR; Iser IC; Onzi GR; Fontoura DMSD; Bertoni APS; Sévigny J; Lenz G; Wink MR
Biochem J; 2019 Jun; 476(11):1637-1651. PubMed ID: 31085558
[TBL] [Abstract][Full Text] [Related]
29. Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
Cardoso AM; Silvério MNO; de Oliveira Maciel SFV
Purinergic Signal; 2021 Dec; 17(4):649-679. PubMed ID: 34590239
[TBL] [Abstract][Full Text] [Related]
30. Purinergic signaling in scarring.
Ferrari D; Gambari R; Idzko M; Müller T; Albanesi C; Pastore S; La Manna G; Robson SC; Cronstein B
FASEB J; 2016 Jan; 30(1):3-12. PubMed ID: 26333425
[TBL] [Abstract][Full Text] [Related]
31. Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.
Bertoni APS; de Campos RP; Tamajusuku ASK; Stefani GP; Braganhol E; Battastini AMO; Wink MR
Life Sci; 2020 Sep; 256():117862. PubMed ID: 32473244
[TBL] [Abstract][Full Text] [Related]
32. Alteration of purinergic signaling in diabetes: Focus on vascular function.
Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
[TBL] [Abstract][Full Text] [Related]
33. The roles of purinergic signaling in psychiatric disorders.
Cieślak M; Czarnecka J; Roszek K
Acta Biochim Pol; 2016; 63(1):1-9. PubMed ID: 26495439
[TBL] [Abstract][Full Text] [Related]
34. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
35. Adenosine triphosphate release and purinergic regulation of cholangiocyte transport.
Feranchak AP; Fitz JG
Semin Liver Dis; 2002 Aug; 22(3):251-62. PubMed ID: 12360419
[TBL] [Abstract][Full Text] [Related]
36. Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells.
Xu C; Shmukler BE; Nishimura K; Kaczmarek E; Rossetti S; Harris PC; Wandinger-Ness A; Bacallao RL; Alper SL
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1464-76. PubMed ID: 19244404
[TBL] [Abstract][Full Text] [Related]
37. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.
Volonté C; Parisi C; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439
[TBL] [Abstract][Full Text] [Related]
38. Purinergic Signaling in Glioma Progression.
Braganhol E; Wink MR; Lenz G; Battastini AMO
Adv Exp Med Biol; 2020; 1202():87-108. PubMed ID: 32034710
[TBL] [Abstract][Full Text] [Related]
39. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
40. Ectonucleotidases in the nervous system.
Zimmermann H
Novartis Found Symp; 2006; 276():113-28; discussion 128-30, 233-7, 275-81. PubMed ID: 16805426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
